These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 5445263)

  • 21. [Behavior of some intervals constituting ventricular systole during measured work in patients with cardiac insufficiency treated with cardiokinetic drugs].
    Iannetti M; Martini U; Caponnetto S
    Minerva Med; 1966 May; 57(43 Suppl):1991-4. PubMed ID: 5943257
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the indices of external respiration and central hemodynamics during the use of nitrates in the therapy of chronic heart failure].
    Samiev UB
    Ter Arkh; 1984; 56(9):58-62. PubMed ID: 6515550
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of cardiac insufficiency with cardiac glycosides].
    Tsyganiĭ AA; Rudenko AF; Kovalev NL; Malinovskiĭ OP; Koziar VV
    Vrach Delo; 1980 Aug; (8):60-3. PubMed ID: 7415132
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiac glycosides in acute cardiac insufficiency].
    Fiehring H; Assmann I; Schmidt H; Hesse P; Banse P
    Dtsch Gesundheitsw; 1972 Oct; 27(43):2024-7. PubMed ID: 5087010
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the specific treatment of senile cardiac insufficiency].
    Köhler U
    Landarzt; 1965 Jan; 41(3):122-4. PubMed ID: 5890170
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 27. [Usefulness of left ventricular contraction period determination by the polygraphic method in the treatment of patients with overt circulatory failure by means of administering cardiac glycosides].
    Smielak-Korombel W
    Pol Tyg Lek; 1976 Sep; 31(38):1641-4. PubMed ID: 980985
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of cardiac glycosides of strophanthin-like action in the pharmacotherapy of chronic circulatory insufficiency].
    Leshchinskiĭ LA; Karbasnikova GV; Zabel'ian OM; Vasil'kova AA
    Kardiologiia; 1978 Mar; 18(3):76-83. PubMed ID: 347140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of congestive heart failure with sodium nitroprusside infusions in association of chronic obstructive lung diseases and postinfarct cardiosclerosis].
    Striuk RI; Barsukova MV; Maksimova LN
    Ross Med Zh; 1992; (2):39-41. PubMed ID: 1643336
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of various peripheral vasodilators on tissue circulation in patients with cardiac insufficiency].
    Aliev EB; Almazov II; Malyshev IuM; Makhatadze LN; Zhumambaeva RM
    Ter Arkh; 1982; 54(5):122-6. PubMed ID: 7101173
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
    Benda L; Zenz W
    Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An alternative to digitalis].
    Ljung O
    Lakartidningen; 1966 Nov; 63(48):4607-12. PubMed ID: 5979947
    [No Abstract]   [Full Text] [Related]  

  • 33. [Some principles of treatment of chronic circulatory insufficiency in the light of the modern concepts of its pathogenesis].
    Dovgiallo OG; Misiukevich II
    Ter Arkh; 1972 Aug; 44(8):110-4. PubMed ID: 5071573
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of cardiac glycosides in circulatory insufficiency].
    Vizir AD
    Vrach Delo; 1969 Nov; 11():39-42. PubMed ID: 5384419
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cardiac insufficiency in the elderly with particular reference to kidney function].
    Rieger J; Scheler F
    Z Gerontol; 1981; 14(5):403-9. PubMed ID: 7029938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current data on the role of cardiac glycosides in the treatment of circulatory insufficiency].
    Valenkevich LN; Lemkina SM
    Klin Med (Mosk); 1989 Jan; 67(1):18-23. PubMed ID: 2654460
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and haemodynamic studies with peruvoside (Cd. 421) in congestive heart failure.
    Bhatia ML; Manchanda SS; Gupta SP; Roy SB
    Indian Heart J; 1971 Apr; 23(2):159-63. PubMed ID: 5154111
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hemodynamic features of patients with circulatory disorders being treated with glycosides].
    Sakharova LP; Starosel'skiĭ IV
    Vrach Delo; 1972 Dec; 12():43-5. PubMed ID: 4659213
    [No Abstract]   [Full Text] [Related]  

  • 39. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
    Luise A
    Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290
    [No Abstract]   [Full Text] [Related]  

  • 40. [Are cardiac glycosides still needed in the treatment of cardiac insufficiency?].
    Böhm M
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2133-8. PubMed ID: 12397560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.